Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin

Christopher W Woods, Allen C. Cheng, Vance G Fowler, Mary Moorefield, Joyce Frederick, George Sakoulas, Venkata G. Meka, Fred C Tenover, Peter Zwadyk, Kenneth K. Wilson

Research output: Contribution to journalArticleResearchpeer-review

48 Citations (Scopus)

Abstract

Clinical management of infective endocarditis (IE) is expected to become more difficult with the emergence of Staphylococcus aureus with reduced susceptibility to vancomycin (SARV) in the United States and worldwide. We report the strain characterization and treatment of a patient with SARV IE.

Original languageEnglish
Pages (from-to)1188-1191
Number of pages4
JournalClinical Infectious Diseases
Volume38
Issue number8
DOIs
Publication statusPublished - 15 Apr 2004
Externally publishedYes

Cite this